Home
Boston Biomedical

Boston Biomedical Market Share Analysis for November 2025

sumitomo pharma oncology is a global developer of novel cancer therapeutics. learn about our diverse and purposeful pipeline of targeted therapies.

Health > Biotechnology and Pharmaceuticals

Domainbostonbiomedical.com

Year Founded2006

Employees51 - 200

Annual Revenue$15M - $25M

Boston Biomedical

Boston Biomedical (including company regionals)

bostonbiomedical.com

See more website traffic and engagement information

Boston Biomedical Revenue up to November 2025 is 15M - 25M

revenue generated by Boston Biomedical top domains

Boston Biomedical top domains revenue over 3 years

Revenue for Boston Biomedical top domains

bostonbiomedical.com15M - 25M

See more with Sales Intelligence

Total visits to Boston Biomedical's top domains

Understand Boston Biomedical market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Boston Biomedical's top domains

Analyze Boston Biomedical engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Boston Biomedical's top domains

See how Boston Biomedical keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Boston Biomedical top competitors by domain

Top similar sites in November 2025, ranked by their affinity

chronixbiomedical.comCompany NameChronix BiomedicalEmployees51 - 200HQUnited States, California, San JoseAnnual revenue$15M - $25MTotal visits--Health > Biotechnology and Pharmaceuticals

Top technologies used by Boston Biomedical

These are the website technologies, by industry, used by Boston Biomedical top domains

Advertising (4)

DoubleClick

Widget (4)

reCAPTCHA

Content Management System (2)

WordPress

Audio Video Media (1)

YouTube

More Technologies

7

See all

News & Signals from Boston Biomedical

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsSumitomo Pharma Co., Ltd acquired Bostonbiomedical for $2.63B on Jan 1st '12.If completed, the deal would rank as this year's fourth-largest disclosed global biopharma M&A transaction and Sumitomo Dainippon's most expensive acquisition to date, topping predecessor Dainippon Sumitomo Pharma's $2.63 billion acquisition of cancer-focused Boston Biomedical Inc. in 2012.

NewsHuebner leaves Bostonbiomedical as head of development.Huebner joined Mersana from Boston Biomedical, where he served as head of development.

NewsBostonbiomedical hired Edgar Braendle as executive vice president, head of research and development, and chief medical officer on Oct 16th '17.Boston Biomedical, Inc., an industry leader in the development of next-generation cancer therapeutics, today announced the appointment of Edgar Braendle, M.D., Ph.D., to Executive Vice President, Head of Research and Development and Chief Medical Officer.